BeiGene (BGNE) Reports Q4 Loss of $4.52/ADS

BeiGene (NASDAQ: BGNE) reported Q4 EPS of ($4.52), versus ($2.19) reported last year. Revenue for the quarter came in at $58.67 million versus the consensus estimate of $66.48 million.

For earnings history and earnings-related data on BeiGene (BGNE) click here.

You May Also Be Interested In

• Tesla to launch Cybercab in Austin this month - report
• INVO Fertility (IVF) Tops Q2 EPS by 105c
• CalPrivate Bank names Andra Frazier as chief credit officer